Finance

Lists
Why is 524372 down 2,04%?
Dive Deeper
524372:BOM
Orchid Pharma Ltd
940,25 INR
-2,04%
(-19,60) 1D
14 ოქტ, 15:30:00 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 524372...
Open
959,85 INR
High
966,45 INR
Low
939,45 INR
Mkt. cap
56,69 მლრდ.
Avg. vol.
6,87 ათ.
Volume
1,89 ათ.
52-wk high
1 142,65 INR
52-wk low
471,30 INR
No. of employees
1 ათ.
Open
959,85 INR
High
966,45 INR
Low
939,45 INR
Mkt. cap
56,69 მლრდ.
Avg. vol.
6,87 ათ.
Volume
1,89 ათ.
52-wk high
1 142,65 INR
52-wk low
471,30 INR
No. of employees
1 ათ.
News stories
From web sources and news partners
Profile
Orchid Pharma Limited is an Indian pharmaceutical company based in Chennai. It was founded by Kailasam Raghavendra Rao on 1 July 1992. Orchid Pharma is the only pharma company in India to have discovered a New Drug Enmetazobactam which is now approved in United States, Europe and India. Wikipedia
About Orchid Pharma Ltd
CEO-
Employees1,17 ათ.
Founded1992
Headquarters-
SectorPharmaceutical industry
Websiteorchidpharma.com
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
1,94 მლრდ.
2,07 მლრდ.
6,59 მლრდ.
3,04 მლრდ.
Cost of goods sold
1,33 მლრდ.
1,43 მლრდ.
5,03 მლრდ.
2,04 მლრდ.
Cost of revenue
1,33 მლრდ.
1,43 მლრდ.
5,03 მლრდ.
2,04 მლრდ.
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
248,51 მლნ.
241,28 მლნ.
502,27 მლნ.
280,38 მლნ.
Operating expense
713,95 მლნ.
715,86 მლნ.
1,40 მლრდ.
968,16 მლნ.
Total operating expenses
2,04 მლრდ.
2,15 მლრდ.
6,43 მლრდ.
3,01 მლრდ.
Operating income
-103,77 მლნ.
-74,65 მლნ.
163,81 მლნ.
30,51 მლნ.
Other non operating income
107,74 მლნ.
56,09 მლნ.
-238,03 მლნ.
18,28 მლნ.
EBT including unusual items
-57,24 მლნ.
-126,14 მლნ.
131,94 მლნ.
32,97 მლნ.
EBT excluding unusual items
-57,24 მლნ.
-55,01 მლნ.
54,86 მლნ.
32,97 მლნ.
Income tax expense
-
-
17,00 ათ.
723,00 ათ.
Effective tax rate
-
-
0,01%
2,19%
Other operating expenses
376,43 მლნ.
384,29 მლნ.
419,31 მლნ.
578,29 მლნ.
Net income
-57,24 მლნ.
-126,14 მლნ.
131,92 მლნ.
32,24 მლნ.
Net profit margin
-2,96%
-6,09%
2,00%
1,06%
Earnings per share
-1,13
-1,08
4,58
0,54
Interest and investment income
-
-
101,25 მლნ.
-
Interest expense
-37,32 მლნ.
-31,78 მლნ.
-
-22,30 მლნ.
Net interest expenses
-37,32 მლნ.
-31,78 მლნ.
101,25 მლნ.
-22,30 მლნ.
Depreciation and amortization charges
89,01 მლნ.
90,29 მლნ.
166,61 მლნ.
109,49 მლნ.
EBITDA
-15,99 მლნ.
10,45 მლნ.
269,63 მლნ.
119,14 მლნ.
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google აპები